Han, Kelong <br/><br/>
Population pharmacokinetics of bevacizumab in cancer patients with external validation.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Aug 2016 
 - 341-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Validation Study 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-016-3079-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiogenesis Inhibitors--administration & dosage<br/>Asian People<br/>Bevacizumab--administration & dosage<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Clinical Trials, Phase IV as Topic<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Half-Life<br/>Humans<br/>Male<br/>Models, Biological<br/>Neoplasms--drug therapy<br/>Sex Factors<br/>Tissue Distribution